ClinicalTrials.gg
CompletedNCT07931976PAULAUpdated Nov 12, 2026

Interactive Patient Education App for Informed Consent Before Cataract Surgery

An interventional study of PAULA interactive patient education app and General control video in Cataract and Informed Consent, sponsored by Johannes Kepler University of Linz. Completed at 1 site in Austria. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Johannes Kepler University of Linz · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jul 2026, registered Nov 2026).
Updated Nov 12, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 11 studies in Cataract by Johannes Kepler University of Linz — 3 open to participants now, 3 under way, none of them phase 3. Cataract · Johannes Kepler University of Linz.

Started
2026
with 1 other
No phase
2 of 11
1 open now
Registered
11th of 11
by date

Among the 11 studies in Cataract by Johannes Kepler University of Linz, this one is one of 2 that started in 2026, is one of 2 with no phase, and was the 11th registered.

Cataract

1,632 studies on the registry are indexed under Cataract; 235 are open to participants now.

Browse Cataract studies →

Open to participants now

3 of the 11 studies in Cataract by Johannes Kepler University of Linz are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 142 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 16 take healthy volunteers.

This study: 21 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Cataract by Johannes Kepler University of Linz, or all of them as a file.
02

Study summary

This randomized controlled trial investigated whether an interactive multimedia patient education app (PAULA), used before the informed consent discussion with a physician, improves patients' knowledge about cataract surgery compared with a general video without medical content.

Read the detailed description

Informed consent before cataract surgery is usually provided verbally and in writing. Patients often retain only part of this information, and the content and duration of consent discussions vary between physicians. PAULA (Patient Education and Learning Application) is an interactive, multimedia tablet application developed for preoperative education of cataract patients. It explains the indication for surgery, the surgical procedure, possible risks and complications, and the postoperative course using animations, audio, text and interactive elements. The app provides generic, standardized information identical in content to the standard consent discussion and the paper consent form; it does not process patient-specific data and has no diagnostic or therapeutic purpose. It is intended to complement, not replace, the physician's consent discussion. This prospective, randomized, controlled, single-center study was conducted at the Department of Ophthalmology and Optometry, Kepler University Hospital Linz, Austria. Adults scheduled for cataract surgery were included after confirmation of eligibility and written informed consent and were allocated by computer-generated randomization in a 2:1 ratio to the intervention group (PAULA app on a tablet) or the control group (general video without cataract-specific content). Subsequently, all participants received the standard face-to-face informed consent discussion with a physician masked to group allocation, and the duration of this discussion was recorded. Participants then completed a 20-item single-choice knowledge questionnaire on cataract surgery, the Decisional Conflict Scale (DCS) and the German version of the Catquest-9SF; participants in the intervention group additionally completed the System Usability Scale (SUS). Enrollment and all data collection took place during a single visit of about one hour on the same day; no follow-up visit was required. Cataract surgery and all medical care were identical in both groups. The study was approved by the Ethics Committee of the Johannes Kepler University Linz (EK 1495/2025).

03

Conditions studied

  • Cataract
  • Informed Consent

Browse trials for

Keywords

  • Patient Education
  • Digital Health
  • Mobile Applications
  • Decision Aid
  • Decisional Conflict
  • Health Literacy
  • Cataract Surgery
04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with unilateral or bilateral cataract scheduled for cataract surgery at Kepler University Hospital Linz
  • Age 21 years or older
  • Capacity to consent
  • Written

Exclusion criteria

Exclusion Criteria:

  • Combined surgical procedures
  • Prior discussion about cataract surgery already completed
  • Insufficient knowledge of the German language
  • Corrected distance visual acuity (CDVA) in the better eye worse than 1.0 logMAR
  • Significant hearing impairment
  • Physical inability to operate a tablet
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    PAULA App

    Participants used the interactive multimedia patient education app PAULA on a tablet before the standard face-to-face informed consent discussion with a physician.

    Behavioral: PAULA interactive patient education app

  • Sham comparator
    Control Video

    Participants watched a general video without cataract-specific medical content before the standard face-to-face informed consent discussion with a physician.

    Behavioral: General control video

Interventions

  • BehavioralPAULA interactive patient education app

    Interactive tablet application (PAULA, Patient Education and Learning Application) explaining the indication, procedure, risks, complications and postoperative course of cataract surgery using animations, audio, text and interactive elements. Content is generic and identical to the standard consent discussion and paper consent form; used once before the physician's consent discussion.

  • BehavioralGeneral control video

    General video without specific medical content regarding cataract or cataract surgery, shown once before the physician's consent discussion.

06

What researchers measure

Primary outcomes

  1. Objective Knowledge About Cataract Surgery

    Score on a 20-item single-choice questionnaire assessing knowledge about cataract, cataract surgery, risks and postoperative course. Score range 0-20 (number of correct answers); higher scores indicate better knowledge.

    Time frame: immediately after the preoperative informed consent discussion

Secondary outcomes

  1. Duration of the Physician's Informed Consent Discussion

    Duration of the face-to-face informed consent discussion between physician and participant, measured in minutes.

    Time frame: immediately after the preoperative informed consent discussion

  2. Decisional Conflict Scale (DCS) Total Score

    Total score of the Decisional Conflict Scale (16 items). Score range 0-100; higher scores indicate greater decisional conflict.

    Time frame: immediately after the preoperative informed consent discussion

  3. Vision-Related Quality of Life (Catquest-9SF, German Version)

    Patient-reported visual function measured with the German version of the 9-item Catquest-9SF questionnaire, analyzed as Rasch-calibrated person score; lower scores indicate fewer difficulties with vision in daily life.

    Time frame: immediately after the preoperative informed consent discussion

  4. Usability of the PAULA App (System Usability Scale)

    System Usability Scale (SUS), 10 items, assessed in the intervention group only. Score range 0-100; higher scores indicate better usability.

    Time frame: immediately after the preoperative informed consent discussion

Other outcomes

  1. Workflow Efficiency as Rated by Clinical Staff

    Individual assessments of clinical staff regarding the efficiency of the preoperative consent workflow.

    Time frame: immediately after the preoperative informed consent discussion

  2. Acceptance of the App and Difficulties Using the Tablet

    Acceptance of the app and difficulties in handling the tablet, documented in written notes by clinical assistant staff.

    Time frame: immediately after the preoperative informed consent discussion

  3. Qualitative Participant Feedback

    Oral qualitative feedback from participants on the informed consent process.

    Time frame: immediately after the preoperative informed consent discussion

07

Study locations

1 site
  • Kepler University Hospital, Department of Ophthalmology and Optometry
    Linz, 4020, Austria
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2026 to primary completion in Oct 2026, 3 months.

Of 303 non-industry interventional studies with no phase under Cataract, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's 3 months is below that.

Counting every sponsor, half of 493 studies reached it within 17 months; a quarter within 9 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 6, 2026
First posted
Nov 12, 2026
StartActual
Jul 23, 2026
Primary completionActual
Oct 29, 2026
CompletionActual
Oct 29, 2026
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07931976
Lead sponsor
Johannes Kepler University of Linz
Collaborators
Kepler University Hospital
Responsible party
Sponsor
First posted
Nov 12, 2026
Start date
Jul 23, 2026
Primary completion
Oct 29, 2026
Completion
Oct 29, 2026
Last update
Nov 12, 2026

Study contacts

Nino Hirnschall, MD, PhD
principal investigator · Johannes Kepler University Linz and Kepler University Hospital, Department of Ophthalmology and Optometry

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion